CRYOPORT, INC. Income Taxes Paid
CRYOPORT, INC. (CYRX) reported Income Taxes Paid of $752.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:IncomeTaxesPaid · last filed 2026-08-06
- CRYOPORT, INC. income taxes paid for the quarter ending 2026-06-30 was $250.00K, a 14.68% increase year-over-year.
- CRYOPORT, INC. income taxes paid for the quarter ending 2026-03-31 was $502.00K, a 23.04% increase year-over-year.
- CRYOPORT, INC. income taxes paid for the quarter ending 2025-12-31 was $1.26M, a 417.28% increase year-over-year.
- CRYOPORT, INC. income taxes paid for the quarter ending 2025-09-30 was $308.00K, a 34.75% decline year-over-year.
- CRYOPORT, INC. income taxes paid for fiscal 2025 was $2.19M, a 54.08% increase from fiscal 2024.
- CRYOPORT, INC. income taxes paid for fiscal 2024 was $1.42M, a 2.74% decline from fiscal 2023.
- CRYOPORT, INC. income taxes paid for fiscal 2023 was $1.46M, a 26.12% decline from fiscal 2022.
- CRYOPORT, INC. income taxes paid for fiscal 2022 was $1.98M, a 50.49% increase from fiscal 2021.
| Period end | Income Taxes Paid 3 month | Income Taxes Paid 6 month | Income Taxes Paid 9 month | Income Taxes Paid 12 month | Income Taxes Paid 12 month as first filed |
|---|---|---|---|---|---|
| 2026-06-30 | $250.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $752.00K 10-Q · filed 2026-08-06 | $2.01M derived: sum of 3 quarters · filed 2026-08-06 | $2.32M derived: sum of 4 quarters · filed 2026-08-06 | |
| 2026-03-31 | $502.00K 10-Q · filed 2026-05-05 | $1.76M derived: sum of 2 quarters · filed 2026-05-05 | $2.07M derived: sum of 3 quarters · filed 2026-05-05 | $2.29M derived: sum of 4 quarters · filed 2026-08-06 | |
| 2025-12-31 | $1.26M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05 | $1.56M derived: sum of 2 quarters · filed 2026-03-05 | $1.78M derived: sum of 3 quarters · filed 2026-08-06 | $2.19M 10-K · filed 2026-03-05 | |
| 2025-09-30 | $308.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $526.00K derived: sum of 2 quarters · filed 2026-08-06 | $934.00K 10-Q · filed 2025-11-06 | $1.18M derived: sum of 4 quarters · filed 2026-08-06 | |
| 2025-06-30 | $218.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $626.00K 10-Q · filed 2026-08-06 | $869.00K derived: sum of 3 quarters · filed 2026-08-06 | $1.34M derived: sum of 4 quarters · filed 2026-08-06 | |
| 2025-03-31 | $408.00K 10-Q · filed 2026-05-05 | $651.00K derived: sum of 2 quarters · filed 2026-05-05 | $1.12M derived: sum of 3 quarters · filed 2026-05-05 | $1.41M derived: sum of 4 quarters · filed 2026-05-05 | |
| 2024-12-31 | $243.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05 | $715.00K derived: sum of 2 quarters · filed 2026-03-05 | $1.00M derived: sum of 3 quarters · filed 2026-03-05 | $1.42M 10-K · filed 2026-03-05 | |
| 2024-09-30 | $472.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $762.00K derived: sum of 2 quarters · filed 2025-11-06 | $1.18M 10-Q · filed 2025-11-06 | $1.69M derived: sum of 4 quarters · filed 2026-03-05 | |
| 2024-06-30 | $290.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-12 | $707.00K 10-Q · filed 2025-08-12 | $1.22M derived: sum of 3 quarters · filed 2026-03-05 | $1.07M derived: sum of 4 quarters · filed 2026-03-05 | |
| 2024-03-31 | $417.00K 10-Q · filed 2025-05-08 | $928.00K derived: sum of 2 quarters · filed 2026-03-05 | $776.00K derived: sum of 3 quarters · filed 2026-03-05 | $1.45M derived: sum of 4 quarters · filed 2026-03-05 | |
| 2023-12-31 | $511.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05 | $359.00K derived: sum of 2 quarters · filed 2026-03-05 | $1.03M derived: sum of 3 quarters · filed 2026-03-05 | $1.46M 10-K · filed 2026-03-05 | |
| 2023-09-30 | -$152.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $518.00K derived: sum of 2 quarters · filed 2024-11-07 | $951.00K 10-Q · filed 2024-11-07 | $1.65M derived: sum of 4 quarters · filed 2025-03-07 | |
| 2023-06-30 | $670.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $1.10M 10-Q · filed 2024-08-08 | $1.81M derived: sum of 3 quarters · filed 2025-03-07 | $2.37M derived: sum of 4 quarters · filed 2025-03-07 | |
| 2023-03-31 | $433.00K 10-Q · filed 2024-05-08 | $1.14M derived: sum of 2 quarters · filed 2025-03-07 | $1.70M derived: sum of 3 quarters · filed 2025-03-07 | $2.38M derived: sum of 4 quarters · filed 2025-03-07 | |
| 2022-12-31 | $703.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-07 | $1.26M derived: sum of 2 quarters · filed 2025-03-07 | $1.95M derived: sum of 3 quarters · filed 2025-03-07 | $1.98M 10-K · filed 2025-03-07 | |
| 2022-09-30 | $562.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $1.24M derived: sum of 2 quarters · filed 2023-11-09 | $1.28M 10-Q · filed 2023-11-09 | ||
| 2022-06-30 | $682.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | $714.00K 10-Q · filed 2023-08-09 | |||
| 2022-03-31 | $32.00K 10-Q · filed 2023-05-04 | ||||
| 2021-12-31 | $1.31M 10-K · filed 2024-03-13 | ||||
| 2020-12-31 | $60.00K 10-K · filed 2023-02-28 | ||||
| 2019-12-31 | $14.00K 10-K · filed 2022-02-28 | $13.89K 10-K · filed 2020-03-10 | |||
| 2018-12-31 | $19.95K 10-K · filed 2020-03-10 | ||||
| 2017-12-31 | $5.14K 10-K · filed 2019-03-13 | ||||
| 2016-12-31 | $5.67K 10-K · filed 2018-03-08 | $5.67K 10-K · filed 2018-03-08 | |||
| 2016-03-31 | $0.00 derived: 10-KT 12 month − 10-KT 9 month · filed 2017-03-13 | $3.63K 10-KT · filed 2017-03-13 | |||
| 2015-12-31 | $3.63K 10-KT · filed 2017-03-13 | ||||
| 2015-03-31 | $1.60K 10-K · filed 2016-06-28 | ||||
| 2014-03-31 | $1.60K derived: 10-K 12 month − 10-Q 9 month · filed 2015-05-19 | $1.60K derived: sum of 2 quarters · filed 2015-05-19 | $1.60K 10-K · filed 2015-05-19 | ||
| 2013-12-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2014-02-13 | $0.00 10-Q · filed 2014-02-13 | |||
| 2013-09-30 | $0.00 10-Q · filed 2013-11-18 | ||||
| 2013-03-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2014-06-25 | $0.00 derived: sum of 2 quarters · filed 2014-06-25 | $1.60K 10-K · filed 2014-06-25 | ||
| 2012-12-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2014-02-13 | $1.60K 10-Q · filed 2014-02-13 | |||
| 2012-09-30 | $1.60K 10-Q · filed 2013-11-18 | ||||
| 2012-03-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2013-06-25 | $0.00 derived: sum of 2 quarters · filed 2013-06-25 | $0.00 derived: sum of 3 quarters · filed 2013-06-25 | $1.60K 10-K · filed 2013-06-25 | |
| 2011-12-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2013-02-14 | $0.00 derived: sum of 2 quarters · filed 2013-02-14 | $1.60K 10-Q · filed 2013-02-14 | $1.60K derived: sum of 4 quarters · filed 2013-02-14 | |
| 2011-09-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2012-11-09 | $1.60K 10-Q · filed 2012-11-09 | $1.60K derived: sum of 3 quarters · filed 2012-11-09 | $1.60K derived: sum of 4 quarters · filed 2012-11-09 | |
| 2011-06-30 | $1.60K 10-Q · filed 2012-08-14 | $1.60K derived: sum of 2 quarters · filed 2012-08-14 | $1.60K derived: sum of 3 quarters · filed 2012-08-14 | $1.60K derived: sum of 4 quarters · filed 2012-08-14 | |
| 2011-03-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2012-06-27 | $0.00 derived: sum of 2 quarters · filed 2012-06-27 | $0.00 derived: sum of 3 quarters · filed 2012-06-27 | $1.60K 10-K · filed 2012-06-27 | |
| 2010-12-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2012-02-21 | $0.00 derived: sum of 2 quarters · filed 2012-02-21 | $1.60K 10-Q · filed 2012-02-21 | ||
| 2010-09-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2011-11-14 | $1.60K 10-Q · filed 2011-11-14 | |||
| 2010-06-30 | $1.60K 10-Q · filed 2011-08-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 | |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |
| Apnimed, Inc. (APMD) | United States | $0.899B | |
| ARDELYX, INC. (ARDX) | United States | $0.857B | -22.86 |
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |